Cash Position
$552,961
Net Income (YTD)
$289,500
Total Ad Spend
$18,400
Website Sessions
6,842
Avg Rating
4.9312 reviews
Total Leads
156
Website Sessions — Last 12 Months
Lead Pipeline
Total Balance
$552,961.23
Source
Plaid
Large Transactions — last 30 days
Restylane Aesthetics Supply Co.
-$9,720.00
Insurance Reimbursement — Cigna
+$15,330.00
Payroll — Gusto
-$55,260.00
Bank Accounts — First Hawaiian Bank
| Account Name | Type | Subtype | Balance |
|---|---|---|---|
| Business Checking | Depository | Checking | $428,641.32 |
| Business Savings | Depository | Savings | $114,660.30 |
| Payroll Checking | Depository | Checking | $9,659.61 |
Total Balance Owed
$43,801.16
Total Available Credit
$81,198.84
Total Credit Limit
$125,000.00
Credit Cards
| Card Name | Issuer | Balance Owed | Available Credit | Credit Limit |
|---|---|---|---|---|
| Business Gold Card | American Express | $29,520.66 | $45,479.34 | $75,000.00 |
| Ink Business Preferred | Chase | $14,280.50 | $35,719.50 | $50,000.00 |
Kalani Medical Clinic
Financial Statements
Profit & Loss
Balance Sheet
Statement of Cash Flows
Profit & Loss Statement
Showing: Last Month (June)
Total Revenue
$107,667
Gross Profit
$69,00064.1%
Operating Expenses
$43,833
Net Income
$24,12522.4%
Revenue by Service Line
| Category | Amount | % of Revenue |
|---|
Cost of Services
| Category | Amount |
|---|
Operating Expenses
| Category | Amount |
|---|
Current Cash Balance
$552,961
Lowest Projected Balance
$480,861Week of Oct 6
13-Week Net Change
-$68,300
Minimum Operating Reserve
$150,000
Projected Ending Balance — 13 Weeks
Projected low point of $480,861 lands the week of October 6, driven by overlapping payroll and the quarterly equipment loan payment. Balance stays well above the $150,000 minimum operating reserve throughout the forecast window — no financing action needed, but worth avoiding any discretionary equipment purchases in early October.
Weekly Detail
| Week | Week Of | Beginning Balance | Cash In | Cash Out | Ending Balance |
|---|
Total Provider Revenue
$1,292,000
Avg Utilization
79.5%
Top Performer
Dr. Kahale$297/hr
Total Provider Compensation
$312,000
Revenue by Provider
Provider Detail
| Provider | Role | Revenue | Hours Booked / Available | Utilization | Compensation | Contribution (Rev − Comp) |
|---|---|---|---|---|---|---|
| Dr. Leilani Kahale, MD | Medical Director | $398,000 | 1,340 / 1,560 | 85.9% | $106,000 | $292,000 |
| Malia Fonoti, NP | Nurse Practitioner / Injector | $312,000 | 1,280 / 1,560 | 82.1% | $74,700 | $237,300 |
| Kai Robello, RN | Aesthetic RN / IV Therapy | $228,000 | 1,190 / 1,560 | 76.3% | $48,500 | $179,500 |
| Sarah Nakamoto, LE | Licensed Esthetician | $214,000 | 1,220 / 1,560 | 78.2% | $39,400 | $174,600 |
| Jordan Meyer, PA-C | Physician Assistant | $140,000 | 780 / 1,040 | 75.0% | $43,400 | $96,600 |
| Total | $1,292,000 | 79.5% | $312,000 | $980,000 |
Total Sales
$107,667
Transactions
650
Avg Sale
$165.64
Sales by Location
| Location | Sales | Transactions | Avg Sale |
|---|---|---|---|
| Honolulu | $51,680 | 312 | $165.64 |
| Waipahu | $32,300 | 195 | $165.64 |
| Kailua | $23,687 | 143 | $165.64 |
Total Leads
156
Total Open
64
Total Closed Won
71
Total Closed Lost
21
Leads by Service
| Service | Leads | Won | Lost |
|---|---|---|---|
| Injectables (Botox & Fillers) | 52 | 26 | 5 |
| Laser & Skin Treatments | 38 | 16 | 6 |
| IV Therapy & Vitamin Injections | 30 | 14 | 4 |
| Body Contouring | 22 | 9 | 3 |
| Medical Weight Loss | 14 | 6 | 3 |
Summit Digital
BluePeak Media
Coral Marketing
Windward Ads
Sessions
6,842
Users
4,910
Bounce Rate
38.2%
Avg Session
2m 14s
Sessions — Last 12 Months
Kalani Honolulu
Kalani Waipahu
Kalani Kailua
Monthly Snapshot
Showing: June
Impressions Trend
Leads Trend — Organic vs. Ads
4.7
312 reviews
Recent Reviews
Kalani Medical Clinic
CEO & CFO Board Report
Quarterly Business Review — Prepared for the Board of Directors
01 — Executive Summary
Business at a Glance
Cash Position
$552,961
Total Revenue
$1,292,000
Net Income
$289,50022.4%
Total Leads
156
Avg Rating
4.9312 reviews
Locations
3
Kalani Medical Clinic closed the period in a strong financial position: $552,961 in cash against $692,601 in total liabilities, a 22.4% net margin, and a 3.2x current ratio that leaves ample liquidity for near-term investment. Revenue growth is broad-based across service lines, led by injectables and laser treatments, and is increasingly reinforced by digital channels — website sessions are up 66% over the trailing twelve months and online reputation remains excellent at 4.9 stars across 312 reviews. The primary watch item heading into next quarter is provider capacity: utilization across the clinical team averages 79.5%, with two providers approaching practical ceiling, which has direct implications for the growth plan discussed in Section 7.
02 — Financial Performance
Revenue, Margin & Cost Structure
Total Revenue
$1,292,000
Gross Margin
64.1%
Operating Expense Ratio
40.7%
Net Margin
22.4%
| Line Item | Amount |
|---|---|
| Total Revenue | $1,292,000 |
| Cost of Services | $464,000 |
| Gross Profit | $828,000 |
| Operating Expenses | $526,000 |
| Operating Income | $302,000 |
| Interest Expense | -$12,500 |
| Net Income | $289,500 |
Injectables and laser/skin treatments together account for 52.6% of total revenue, giving the practice a defensible core built on high-margin, repeat-visit services. Clinical staff wages are the single largest cost line at $312,000 — appropriate given a 79.5% average utilization rate, discussed further in Section 4. Operating expense ratio of 40.7% is in line with well-run single/dual-location med spas; the largest opportunity for margin improvement is in marketing spend efficiency, addressed in Section 5.
03 — Cash Position & Liquidity
Balance Sheet Strength & Forward Cash View
Cash Position
$552,961
Current Ratio
3.2x
Total Debt
$591,801
Debt-to-Equity
1.05x
13-week rolling forecast projects a low point of $480,861 the week of October 6 — comfortably above the $150,000 minimum operating reserve. No financing action required this quarter.
| Obligation | Balance |
|---|---|
| Credit Card Balances | $43,801 |
| Equipment Financing (incl. current portion) | $350,000 |
| Buildout Loan | $198,000 |
| Total Debt | $591,801 |
04 — Operational Performance
Provider Capacity & Contribution
Avg Utilization
79.5%
Top Performer
Dr. Kahale$297/hr
Total Provider Comp
$312,000
Total Contribution
$980,000
Dr. Kahale and Malia Fonoti, NP together generate 54.9% of clinical revenue at above-average utilization (85.9% and 82.1% respectively) — both are approaching practical capacity ceilings. Jordan Meyer, PA-C is part-time at 1,040 available hours and represents the clearest near-term lever to add capacity without a new hire. Recommend evaluating a capacity expansion (see Section 7) before utilization constraints begin capping revenue growth.
05 — Growth & Marketing
Pipeline, Acquisition Cost & Digital Trend
Total Leads
156
Close Rate
77.2%
Blended Cost / Lead
$167.27
Website Sessions
6,842
Ad Spend by Agency
Website Sessions — 12 Months
Summit Digital delivers the strongest volume at the lowest cost per lead ($163.16); Windward Ads trails the group on efficiency. Of 156 total leads this period, 110 are ads-attributed — the remaining 46 come from organic, referral, and reputation channels (Yelp, Google Business Pages), underscoring the value of the digital presence work in Section 6. Close rate of 77.2% on decided leads is strong for the category.
06 — Multi-Location & Digital Presence
Honolulu vs. Waipahu vs. Kailua
| Metric | Honolulu | Waipahu | Kailua |
|---|---|---|---|
| POS Sales | $51,680 | $32,300 | $23,687 |
| POS Transactions | 312 | 195 | 143 |
| GBP Rating | 4.9★ | 4.8★ | 4.9★ |
| GBP Total Reviews | 198 | 142 | 76 |
| GBP Profile Views | 2,140 | 1,450 | 980 |
Honolulu remains the flagship location by both revenue and engagement, with Waipahu establishing itself as a solid second market and Kailua — the newest and smallest of the three — already posting the strongest average rating (4.9★) despite the lowest volume. Waipahu's slightly lower rating (4.8 vs. 4.9 at the other two) traces to weekend capacity constraints on the IV therapy bar rather than clinical quality — an operational fix, not a reputational one. All three locations maintain strong, review-verified reputations that support the growth case in Section 7.
07 — Strategic Recommendations
Priorities for the Board
1. Evaluate a third clinical hire to relieve provider capacity constraints
Dr. Kahale and Malia Fonoti are both above 82% utilization. Without added capacity, revenue growth in injectables and IV therapy will plateau regardless of marketing investment.
2. Reallocate 10–15% of Windward Ads budget to Summit Digital
Summit's cost per lead ($163.16) is meaningfully below the blended average; shifting spend improves overall marketing efficiency with no new budget required.
3. Formalize a cash reserve policy tied to the 13-week forecast
Current liquidity is strong (3.2x current ratio), but a documented minimum reserve threshold protects against payroll/loan timing overlaps like the one projected for early October.
4. Address Waipahu weekend capacity constraints
A scheduling or staffing adjustment on the IV therapy bar is the most likely low-cost fix to close the rating gap with the other two locations (4.8 vs. 4.9) and protect Waipahu's reputation trajectory.
5. Explore a formal membership tier expansion
Membership revenue ($96,000) is the smallest line on the P&L but carries the highest retention value — worth a dedicated push given the strong repeat-visit behavior already seen in IV therapy and injectables.
Exit Readiness Score
76/ 100
Current Valuation (Est.)
$2.15M$1.65M–$2.64M range
Target Acquisition Value
$10.0M
Current EBITDA (TTM)
$330,000
You're Building a Business Buyers Want
A 76/100 readiness score puts Kalani Medical Clinic well ahead of most independent practices at this stage — a strong digital reputation, a proven multi-location model, and real financial systems already in place (the fact that this dashboard exists is itself a point in your favor to a buyer). The gap between today's roughly $2.1M valuation and the $10M target is real, but it's a growth problem, not a readiness problem — the roadmap below shows exactly what closes it.
Exit Readiness Breakdown
Current Valuation Range
| Scenario | EBITDA Multiple | Implied Valuation |
|---|---|---|
| Conservative (independent buyer) | 5.0x | $1,650,000 |
| Market rate | 6.5x | $2,145,000 |
| Premium (strategic / PE) | 8.0x | $2,640,000 |
Path to a $10M Exit
Roadmap Detail
| Stage | Locations | EBITDA | Target Multiple | Implied Value |
|---|---|---|---|---|
| Today | 3 | $330,000 | 6.5x | $2,145,000 |
| Phase 1 — Yr 1–2 | 3 | $550,000 | 7.0x | $3,850,000 |
| Phase 2 — Yr 2–3 | 4 | $850,000 | 7.5x | $6,375,000 |
| Phase 3 — Yr 3–5 | 4 | $1,300,000 | 8.0x | $10,400,000 |
Phase 1 grows EBITDA at the existing 3 locations through membership expansion and provider capacity; a fourth location (e.g. Kapolei) opens in Phase 2. Growth here comes primarily from deepening each location, not opening many new ones.
Acquisition Scenarios
Available Now
Independent / Local Buyer
A single-practice operator or small regional group acquires the business as-is. Fastest path to close, typically cash or seller-financed, lighter diligence.
Multiple5.0–6.0x
Est. Value$1.65M–$1.98M
Available Now
PE-Backed Platform / Roll-Up
A private equity-backed med spa consolidator adds Kalani as a platform or bolt-on acquisition. Rewards multi-location systems and membership revenue; usually structured with seller rollover equity.
Multiple7.0–9.0x
Est. Value$2.31M–$2.97M
4–5 Year Target
Strategic Growth to $10M
Hold and execute the roadmap below — deepen the 3 existing locations, then add a 4th — and exit once EBITDA and recurring revenue reach scale. May involve a minority growth investment along the way to fund the expansion.
Plan targets 4 total locations
Multiple7.5–8.5x
Est. Value$10.0M+
What Buyers Will Diligence